Literature DB >> 31338723

HDL functionality in follicular fluid in normal-weight and obese women undergoing assisted reproductive treatment.

Tiziana Bacchetti1, Camilla Morresi2, Arianna Vignini3, Luca Tiano2, Patrick Orlando2, Nina Montik4, Andrea Ciavattini4, Gianna Ferretti3.   

Abstract

OBJECTIVE: High-density lipoproteins (HDL) exert pleiotropic roles in follicular fluid (FF). Previous studies have reported a relationship between obesity, infertility, and systemic oxidative stress. The aim of our study was to investigate for the first time the HDL functional properties in FF in obesity.
METHODS: In this observational study, overweight/obese (n = 20) and normal-weight women (n = 38) undergoing assisted reproductive technology were included. Compositional properties and biochemical marker of functionality (HDL oxidation rate), HDL-associated antioxidants (paraoxonase-1 activities and CoQ10 content), and lipid hydroperoxide levels were evaluated in FF from normal-weight and overweight/obese women. Correlations between biochemical parameters and indices for oocyte and embryo quality were studied.
RESULTS: FF-HDL obtained from overweight/obese women are characterized by high intrinsic ability to be oxidized compared with FF-HDL from normal-weight women. These alterations are associated with lower activities of paraoxonase-1 (PON1), higher levels of lipid peroxidation, and a lower total antioxidant capacity in FF. Moreover, an association between PON1 activity and FF-HDL oxidation and clinical parameter of oocyte quality was observed.
CONCLUSION: Our data suggest that the quality of FF-HDL is important determinant for oocyte quality. Therefore, targeting FF-HDL functionality, in addition to FF-HDL-C levels, may represent a promising and interesting biomarker for reproductive outcomes.

Entities:  

Keywords:  Assisted reproductive treatment; Follicular fluid; High-density lipoproteins; Obesity; Oxidative stress; Paraoxonase-1

Mesh:

Substances:

Year:  2019        PMID: 31338723      PMCID: PMC6708027          DOI: 10.1007/s10815-019-01523-9

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  5 in total

Review 1.  Dyslipidemia Management in Pregnancy: Why Is It not Covered in the Guidelines?

Authors:  Joanna Lewek; Maciej Banach
Journal:  Curr Atheroscler Rep       Date:  2022-04-30       Impact factor: 5.967

2.  Serum Lipid Levels and Treatment Outcomes in Women Undergoing Assisted Reproduction: A Retrospective Cohort Study.

Authors:  Wang-Yu Cai; Xi Luo; Erxidi Chen; Houyi Lv; Kaiyou Fu; Xiao-Ke Wu; Jian Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-08       Impact factor: 5.555

3.  A Multi-Omics Analysis of PON1 Lactonase Activity in Relation to Human Health and Disease.

Authors:  Boštjan Petrič; Tanja Kunej; Aljoša Bavec
Journal:  OMICS       Date:  2020-12-11

4.  Effect of Hyperinsulinemia and Insulin Resistance on Endocrine, Metabolic, and Reproductive Outcomes in Non-PCOS Women Undergoing Assisted Reproduction: A Retrospective Cohort Study.

Authors:  Wang-Yu Cai; Xi Luo; Jianyuan Song; Danpin Ji; Jun Zhu; Cuicui Duan; Wei Wu; Xiao-Ke Wu; Jian Xu
Journal:  Front Med (Lausanne)       Date:  2022-01-07

5.  Altered redox status may contribute to aberrant folliculogenesis and poor reproductive outcomes in women with polycystic ovary syndrome.

Authors:  Aalaap Naigaonkar; Roshan Dadachanji; Indira Hinduja; Srabani Mukherjee
Journal:  J Assist Reprod Genet       Date:  2021-05-26       Impact factor: 3.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.